Charles River to Provide CGT Testing for Magellan Stem Cells
Charles River will provide cGMP NGS viral safety and release testing for Magellan Stem Cells’ Zelestrocel program as it advances toward Phase III and potential commercialization.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Charles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine Development
For best results when printing this announcement, please click on link below: Charles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine Development Collaboration leverages next-generation sequencing (NGS) services to advance development and commercialization of an off-the-shelf